Effects of Dexmedetomidine on Acute Kidney Injury and Perioperative Outcomes in Aortic Vascular Surgery: A Systematic Review and Meta-Analysis
Seminars in Cardiothoracic and Vascular Anesthesia · 2025
DOI: 10.1177/10892532251346645 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Seminars in Cardiothoracic and Vascular Anesthesia, 2025. Verfasst von Tallal Mushtaq Hashmi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia, Rawalpindi Medical University, Rawalpindi, Pakistan. Hauptthemen laut MEDLINE: Dexmedetomidine, Acute Kidney Injury, Postoperative Complications, Vascular Surgical Procedures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Dexmedetomidine, a highly selective α2-adrenergic receptor agonist, may help mitigate postoperative complications in patients undergoing aortic vascular surgery. Methodology: A comprehensive search was conducted across PubMed, the Cochrane Library, and Embase to identify studies assessing the efficacy and safety of dexmedetomidine compared with placebo in patients undergoing aortic vascular surgery. A random effects meta-analysis was performed with R version 4.4.1 using the “meta” package.
Results
Our analysis included eleven studies, comprising eight RCTs and three cohort studies, with a combined total of 1731 patients. The results showed that dexmedetomidine significantly reduced acute kidney injury (OR 0.49, 95% CI 0.25 to 0.98), ICU length of stay (MD −0.25 days, 95% CI −0.47 to −0.02), postoperative pulmonary complications (OR 0.55, 95% CI 0.32 to 0.94), and CRP levels 24 h post-surgery (MD −24.73 mg/L, 95% CI −46.29 to −3.16) compared to the control group. The length of hospital stay (MD -0.87 days, 95% CI −2.57 to 1.01), postoperative delirium (OR 0.78, 95% CI 0.43 to 1.42), and in-hospital mortality (OR 0.57, 95% CI 0.29 to 1.12) were not significantly different between the two groups.
Conclusion
In patients undergoing aortic vascular surgery, dexmedetomidine administration is associated with reduced acute kidney injury, length of ICU stay, postoperative pulmonary complications, and CRP levels 24 h post-surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesia, Rawalpindi Medical University, Rawalpindi, Pakistan.
- Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
- Department of Cardiology, Imperial College London, UK.
- Department of Cardiology, Royal Brompton Hospital, London, UK.
- Department of Vascular Surgery, North Alabama Medical Center, Florence, AL, USA.
- Adjunct Clinical Faculty, Kentucky College of Osteopathic Medicine, Pikeville, KY, USA.
ORCID-Profile: Tallal Mushtaq Hashmi
Zitieren
APA
Hashmi, T. M., Ashraf, H., Burhan, M., Zia, R., Ahmed, M., Ahmed, R., & Aized, M. T. (2025). Effects of Dexmedetomidine on Acute Kidney Injury and Perioperative Outcomes in Aortic Vascular Surgery: A Systematic Review and Meta-Analysis. Seminars in Cardiothoracic and Vascular Anesthesia. https://doi.org/10.1177/10892532251346645
Vancouver
Hashmi TM, Ashraf H, Burhan M, Zia R, Ahmed M, Ahmed R, et al. Effects of Dexmedetomidine on Acute Kidney Injury and Perioperative Outcomes in Aortic Vascular Surgery: A Systematic Review and Meta-Analysis. Seminars in Cardiothoracic and Vascular Anesthesia. 2025. doi:10.1177/10892532251346645
BibTeX
@article{Hashmi2025,
author = {Hashmi, Tallal Mushtaq and Ashraf, Hadiah and Burhan, Muhammad and Zia, Rohma and Ahmed, Mushood and Ahmed, Raheel and Aized, Majid Toseef},
title = {Effects of Dexmedetomidine on Acute Kidney Injury and Perioperative Outcomes in Aortic Vascular Surgery: A Systematic Review and Meta-Analysis},
journal = {Seminars in Cardiothoracic and Vascular Anesthesia},
year = {2025},
doi = {10.1177/10892532251346645}
}
EUVIMED